97 related articles for article (PubMed ID: 17402972)
1. Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.
Zoffmann S; Bertrand S; Do QT; Bertrand D; Rognan D; Hibert M; Galzi JL
J Neurochem; 2007 Apr; 101(2):506-16. PubMed ID: 17402972
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of the peptide agonist-binding site in a neurokinin-2 receptor.
Chandrashekaran IR; Rao GS; Cowsik SM
J Chem Inf Model; 2009 Jul; 49(7):1734-40. PubMed ID: 19534508
[TBL] [Abstract][Full Text] [Related]
3. A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.
Maillet EL; Pellegrini N; Valant C; Bucher B; Hibert M; Bourguignon JJ; Galzi JL
FASEB J; 2007 Jul; 21(9):2124-34. PubMed ID: 17371796
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Met297 in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A.
Labrou NE; Bhogal N; Hurrell CR; Findlay JB
J Biol Chem; 2001 Oct; 276(41):37944-9. PubMed ID: 11489908
[TBL] [Abstract][Full Text] [Related]
5. Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.
Valant C; Maillet E; Bourguignon JJ; Bucher B; Utard V; Galzi JL; Hibert M
J Med Chem; 2009 Oct; 52(19):5999-6011. PubMed ID: 19746979
[TBL] [Abstract][Full Text] [Related]
6. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor.
Bhogal N; Donnelly D; Findlay JB
J Biol Chem; 1994 Nov; 269(44):27269-74. PubMed ID: 7961636
[TBL] [Abstract][Full Text] [Related]
7. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
[TBL] [Abstract][Full Text] [Related]
8. Dynamic confinement of NK2 receptors in the plasma membrane. Improved FRAP analysis and biological relevance.
Cézanne L; Lecat S; Lagane B; Millot C; Vollmer JY; Matthes H; Galzi JL; Lopez A
J Biol Chem; 2004 Oct; 279(43):45057-67. PubMed ID: 15294896
[TBL] [Abstract][Full Text] [Related]
9. Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.
Gembitsky DS; Murnin M; Otvös FL; Allen J; Murphy RF; Lovas S
J Med Chem; 1999 Jul; 42(15):3004-7. PubMed ID: 10425111
[TBL] [Abstract][Full Text] [Related]
10. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the mammalian tachykinin peptide neurokinin A bound to lipid micelles.
Chandrashekar IR; Cowsik SM
Biophys J; 2003 Dec; 85(6):4002-11. PubMed ID: 14645089
[TBL] [Abstract][Full Text] [Related]
12. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
Turcatti G; Vogel H; Chollet A
Biochemistry; 1995 Mar; 34(12):3972-80. PubMed ID: 7696262
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.
Warner FJ; Miller RC; Burcher E
Biochem Pharmacol; 2002 Jun; 63(12):2181-6. PubMed ID: 12110377
[TBL] [Abstract][Full Text] [Related]
14. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A.
Comis A; Burcher E
J Pept Res; 1999 Mar; 53(3):337-42. PubMed ID: 10231723
[TBL] [Abstract][Full Text] [Related]
16. Binding and functional potency of neurokinin A analogues in the rat fundus: A structure-activity study.
Matuszek MA; Comis A; Burcher E
Pharmacology; 1999 May; 58(5):227-35. PubMed ID: 10087463
[TBL] [Abstract][Full Text] [Related]
17. Distribution pattern of tachykinin NK2 receptors in human colon: involvement in the regulation of intestinal motility.
Jaafari N; Khomitch-Baud A; Christen MO; Julé Y
J Comp Neurol; 2007 Jul; 503(3):381-91. PubMed ID: 17503489
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses.
Lecat S; Bucher B; Mely Y; Galzi JL
J Biol Chem; 2002 Nov; 277(44):42034-48. PubMed ID: 12185075
[TBL] [Abstract][Full Text] [Related]
19. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites.
Turcatti G; Nemeth K; Edgerton MD; Meseth U; Talabot F; Peitsch M; Knowles J; Vogel H; Chollet A
J Biol Chem; 1996 Aug; 271(33):19991-8. PubMed ID: 8702716
[TBL] [Abstract][Full Text] [Related]
20. Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.
Madsen JJ; Petersen JE; Christensen DP; Hansen JB; Schwartz TW; Frimurer TM; Olsen OH
J Biol Chem; 2023 Dec; 299(12):105438. PubMed ID: 37944618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
